Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.

We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.

We equip clinicians with annotation that combines multi-omic data, clinical analytics and treatment guidelines to reveal relevant information for diagnosis, therapy options and response prediction.

Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.

We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.

Our broad expertise integrating diverse datasets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.

Our data and knowledge bases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.

These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics— closing the loop and setting the standard for omics-based healthcare.